15 Penny Stocks Poised To Explode According To Hedge Funds

Page 12 of 16

11. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

At the end of June, there were 17 funds long Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), which held $79.57 million worth of stock, equal to 23.80% of float. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has recently submitted its NDA for its lead product, Tavalisse, a drug for the treatment of patients suffering from chronic or persistent thrombocytopenia. The FDA should make its decision by April 2018 and the approval of the drug would allow Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) to take advantage of a new and growing market that is expected to reach $566 million worldwide by 2020.

Page 12 of 16